Phase III Study of the Efficacy and Safety of Subcutaneous Versus Intravenous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

OBJECTIVE: To evaluate the efficacious noninferiority of subcutaneous tocilizumab injection (TCZ-SC) monotherapy to intravenous TCZ infusion (TCZ-IV) monotherapy in Japanese patients with rheumatoid arthritis (RA) with an inadequate response to synthetic and/or biologic disease-modifying antirheumat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Arthritis Care Res (Hoboken)
Auteurs principaux: Ogata, Atsushi, Tanimura, Kazuhide, Sugimoto, Toyohiko, Inoue, Hiroshi, Urata, Yukitomo, Matsubara, Tsukasa, Kondo, Masakazu, Ueki, Yukitaka, Iwahashi, Mitsuhiro, Tohma, Shigeto, Ohta, Shuji, Saeki, Yukihiko, Tanaka, Toshio
Format: Artigo
Langue:Inglês
Publié: Blackwell Publishing Ltd 2014
Sujets:
Rheumatoid Arthritis
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225471/
https://ncbi.nlm.nih.gov/pubmed/23983039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22110
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires